Literature DB >> 17173329

Triplet repeat in the Repin1 3'-untranslated region on rat chromosome 4 correlates with facets of the metabolic syndrome.

Nora Klöting1, Barbara Wilke, Ingrid Klöting.   

Abstract

BACKGROUND: Congenic and subcongenic rat strains confirmed the quantitative trait loci (QTLs) for facets of the metabolic syndrome between 60.53 and 77.11 Mb on chromosome 4. The analysis of candidate genes in this region favoured the replication initiator 1 (Repin1) characterized by a SNP in the coding region and a triplet repeat (TTT) in the 3'-untranslated region (3'UTR).
METHODS: We analysed nine rat strains (BB/OK, SHR, F344, BN, DA, LEW, hHTg, WOKW, and their founders WOK-F) and four wild rats on DNA (sequencing) and RNA level (gene expression in blood, liver, subcutaneous, and epididymal adipocytes). In addition, the rats were phenotypically characterized in order to link the rat phenotype to genotype differences in the QTL on chromosome 4.
RESULTS: Wild rats were heterozygous for the SNP (C/T), whereas all the inbred strains were homozygous. The shortest triplet repeat was found in SHR (5) and the highest was found in hHTg and WOKW (11), which developed metabolic disorders. The repeat number correlated with most phenotypic traits studied. Using linear multiple regression analysis with repeat size as the dependent variable and considering all the data of this study, it was clearly demonstrated that not only VLDL cholesterol and serum insulin but also the expression of Repin1 in the liver is significantly associated with the repeat size of the 3'UTR.
CONCLUSIONS: It is concluded that the triplet repeat expansion in 3'UTR is involved in metabolic alterations as found in hHTg and WOKW rats and that the functional unknown gene, Repin1, could be a novel candidate gene for the development of facets of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17173329     DOI: 10.1002/dmrr.713

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  8 in total

1.  Rat Models of Metabolic Syndrome.

Authors:  Anne E Kwitek
Journal:  Methods Mol Biol       Date:  2019

2.  Repin1 deficiency in adipose tissue improves whole-body insulin sensitivity, and lipid metabolism.

Authors:  N Hesselbarth; A Kunath; M Kern; M Gericke; N Mejhert; M Rydén; M Stumvoll; M Blüher; N Klöting
Journal:  Int J Obes (Lond)       Date:  2017-07-24       Impact factor: 5.095

3.  Gene expression profiling supports the role of Repin1 in the pathophysiology of metabolic syndrome.

Authors:  Jeanette Bahr; Nora Klöting; Ingrid Klöting; Niels Follak
Journal:  Endocrine       Date:  2011-06-24       Impact factor: 3.633

4.  Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene.

Authors:  J M Fuller; M Bogdani; T D Tupling; R A Jensen; R Pefley; S Manavi; L Cort; E P Blankenhorn; J P Mordes; A Lernmark; A E Kwitek
Journal:  Physiol Genomics       Date:  2009-04-07       Impact factor: 3.107

5.  Low-anxiety rat phenotypes can be further reduced through genetic intervention.

Authors:  Gabriela Ferreira de Medeiros; Elayne Pereira; Natalli Granzotto; André Ramos
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

6.  Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients.

Authors:  Tingting Qi; Jian Qu; Chao Tu; Qiong Lu; Guohua Li; Jiaojiao Wang; Qiang Qu
Journal:  Front Cell Dev Biol       Date:  2020-12-03

7.  Ramipril Reduces Acylcarnitines and Distinctly Increases Angiotensin-Converting Enzyme 2 Expression in Lungs of Rats.

Authors:  Joanna Kosacka; Claudia Berger; Uta Ceglarek; Anne Hoffmann; Matthias Blüher; Nora Klöting
Journal:  Metabolites       Date:  2022-03-26

8.  Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration.

Authors:  Kerstin Abshagen; Bastian Degenhardt; Marie Liebig; Anna Wendt; Berit Genz; Ute Schaeper; Michael Stumvoll; Ute Hofmann; Marcus Frank; Brigitte Vollmar; Nora Klöting
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.